We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Gyros AB Launches New Website

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Gyros AB has launched a new website (www.gyros.com).

The re-designed site features application-focused information demonstrating the value of the Gyros platform in biopharma R&D, to improve resource use, immunoassay quality, and turnaround times.

The Gyros nanoliter-scale immunoassay platform utilizes microfluidic technology to automate highly controlled immunoassays, providing high quality, traceable data to help meet regulatory standards.

Assays developed on the Gyros platform transfer easily between sites and from development to regulated environments.

The platform is used by major biopharmaceutical companies and their service providers worldwide to improve productivity and efficiency during the development of biotherapeutics and vaccines, boosting time-critical workflows.

The new Gyros website presents enhanced content including application note downloads, webinars featuring customer presentations, and product information sheets.

Gyros will host a series of seminars in Europe and the US during 2013, for customers and researchers working in the biopharma industry.

Recordings of presentations give at past seminars are available on the website.